116 related articles for article (PubMed ID: 37451478)
1. Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer.
Gau D; Daoud A; Allen A; Joy M; Sagan A; Lee S; Lucas PC; Duensing S; Boone D; Osmanbeyoglu HU; Roy P
J Biol Chem; 2023 Aug; 299(8):105044. PubMed ID: 37451478
[TBL] [Abstract][Full Text] [Related]
2. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.
Allen A; Gau D; Francoeur P; Sturm J; Wang Y; Martin R; Maranchie J; Duensing A; Kaczorowski A; Duensing S; Wu L; Lotze MT; Koes D; Storkus WJ; Roy P
J Biol Chem; 2020 Nov; 295(46):15636-15649. PubMed ID: 32883810
[TBL] [Abstract][Full Text] [Related]
3. Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma.
Karamchandani JR; Gabril MY; Ibrahim R; Scorilas A; Filter E; Finelli A; Lee JY; Ordon M; Pasic M; Romaschin AD; Yousef GM
Hum Pathol; 2015 May; 46(5):673-80. PubMed ID: 25704627
[TBL] [Abstract][Full Text] [Related]
4. Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization.
Gau D; Vignaud L; Allen A; Guo Z; Sahel J; Boone D; Koes D; Guillonneau X; Roy P
J Biol Chem; 2020 Jul; 295(28):9618-9629. PubMed ID: 32444495
[TBL] [Abstract][Full Text] [Related]
5. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness.
Zou L; Jaramillo M; Whaley D; Wells A; Panchapakesa V; Das T; Roy P
Br J Cancer; 2007 Nov; 97(10):1361-71. PubMed ID: 17940506
[TBL] [Abstract][Full Text] [Related]
6. Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis.
Yao W; Ji S; Qin Y; Yang J; Xu J; Zhang B; Xu W; Liu J; Shi S; Liu L; Liu C; Long J; Ni Q; Li M; Yu X
Mol Cancer; 2014 Aug; 13():187. PubMed ID: 25103363
[TBL] [Abstract][Full Text] [Related]
7. Structure-based virtual screening identifies a small-molecule inhibitor of the profilin 1-actin interaction.
Gau D; Lewis T; McDermott L; Wipf P; Koes D; Roy P
J Biol Chem; 2018 Feb; 293(7):2606-2616. PubMed ID: 29282288
[TBL] [Abstract][Full Text] [Related]
8. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis.
Ding Z; Joy M; Bhargava R; Gunsaulus M; Lakshman N; Miron-Mendoza M; Petroll M; Condeelis J; Wells A; Roy P
Oncogene; 2014 Apr; 33(16):2065-74. PubMed ID: 23686314
[TBL] [Abstract][Full Text] [Related]
9. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
[TBL] [Abstract][Full Text] [Related]
10. Human profilin 1 is a negative regulator of CTL mediated cell-killing and migration.
Schoppmeyer R; Zhao R; Cheng H; Hamed M; Liu C; Zhou X; Schwarz EC; Zhou Y; Knörck A; Schwär G; Ji S; Liu L; Long J; Helms V; Hoth M; Yu X; Qu B
Eur J Immunol; 2017 Sep; 47(9):1562-1572. PubMed ID: 28688208
[TBL] [Abstract][Full Text] [Related]
11. A balanced level of profilin-1 promotes stemness and tumor-initiating potential of breast cancer cells.
Jiang C; Ding Z; Joy M; Chakraborty S; Kim SH; Bottcher R; Condeelis J; Singh S; Roy P
Cell Cycle; 2017; 16(24):2366-2373. PubMed ID: 28699810
[TBL] [Abstract][Full Text] [Related]
12. Profilin-1 is dysregulated in endometroid (type I) endometrial cancer promoting cell proliferation and inhibiting pro-inflammatory cytokine production.
George L; Winship A; Sorby K; Dimitriadis E; Menkhorst E
Biochem Biophys Res Commun; 2020 Oct; 531(4):459-464. PubMed ID: 32800551
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HLA-F-AS1 promotes colorectal cancer metastasis by inducing PFN1 in colorectal cancer-derived extracellular vesicles and mediating macrophage polarization.
Zhang J; Li S; Zhang X; Li C; Zhang J; Zhou W
Cancer Gene Ther; 2021 Dec; 28(12):1269-1284. PubMed ID: 33531647
[TBL] [Abstract][Full Text] [Related]
14. Profilin-1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells.
Das T; Bae YH; Wells A; Roy P
J Cell Physiol; 2009 Feb; 218(2):436-43. PubMed ID: 18937284
[TBL] [Abstract][Full Text] [Related]
15. Identification of profilin 1 as the primary target for the anti-cancer activities of Furowanin A in colorectal cancer.
Zhao J; Xu J; Lv J
Pharmacol Rep; 2019 Oct; 71(5):940-949. PubMed ID: 31454697
[TBL] [Abstract][Full Text] [Related]
16. Trophoblast Exosomal UCA1 Induces Endothelial Injury through the PFN1-RhoA/ROCK Pathway in Preeclampsia: A Human-Specific Adaptive Pathogenic Mechanism.
Wu S; Cui Y; Zhao H; Xiao X; Gong L; Xu H; Zhou Q; Ma D; Li X
Oxid Med Cell Longev; 2022; 2022():2198923. PubMed ID: 36160709
[TBL] [Abstract][Full Text] [Related]
17. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation.
Zou L; Ding Z; Roy P
J Cell Physiol; 2010 Jun; 223(3):623-9. PubMed ID: 20143334
[TBL] [Abstract][Full Text] [Related]
18. Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.
Frantzi M; Klimou Z; Makridakis M; Zoidakis J; Latosinska A; Borràs DM; Janssen B; Giannopoulou I; Lygirou V; Lazaris AC; Anagnou NP; Mischak H; Roubelakis MG; Vlahou A
Oncotarget; 2016 Oct; 7(43):70750-70768. PubMed ID: 27683119
[TBL] [Abstract][Full Text] [Related]
19. Epithelial morphological reversion drives Profilin-1-induced elevation of p27(kip1) in mesenchymal triple-negative human breast cancer cells through AMP-activated protein kinase activation.
Jiang C; Veon W; Li H; Hallows KR; Roy P
Cell Cycle; 2015; 14(18):2914-23. PubMed ID: 26176334
[TBL] [Abstract][Full Text] [Related]
20. Profilin-1 deficiency leads to SMAD3 upregulation and impaired 3D outgrowth of breast cancer cells.
Chakraborty S; Jiang C; Gau D; Oddo M; Ding Z; Vollmer L; Joy M; Schiemann W; Stolz DB; Vogt A; Ghosh S; Roy P
Br J Cancer; 2018 Oct; 119(9):1106-1117. PubMed ID: 30318519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
